Pignon JP - Search Results

1

A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.

Baujat B, Mahé C, Pignon JP, Hill C. Baujat B, et al. Among authors: pignon jp. Stat Med. 2002 Sep 30;21(18):2641-52. doi: 10.1002/sim.1221. Stat Med. 2002. PMID: 12228882

2

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. Pignon JP, et al. N Engl J Med. 1992 Dec 3;327(23):1618-24. doi: 10.1056/NEJM199212033272302. N Engl J Med. 1992. PMID: 1331787

3

[Adjuvant chemotherapy in non-small cell lung cancer].

Taillade L, Soria JC, André F, Grunenwald D, Dunant A, Pignon JP, Le Chevalier T. Taillade L, et al. Among authors: pignon jp. Bull Cancer. 2004 Jan;91(1):63-7. Bull Cancer. 2004. PMID: 14975806 Review. French.

4

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck.

Pignon JP, Syz N, Posner M, Olivares R, Le Lann L, Yver A, Dunant A, Lewin F, Dalley DN, Paccagnella A, Taylor SG, Domenge C, Bourhis J, Mazumdar M. Pignon JP, et al. Anticancer Drugs. 2004 Apr;15(4):331-40. doi: 10.1097/00001813-200404000-00004. Anticancer Drugs. 2004. PMID: 15057136

5

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.

Bourhis J, Etessami A, Wilbault P, Lusinchi A, Calais G, Lapeyre M, Pignon JP. Bourhis J, et al. Among authors: pignon jp. Curr Opin Oncol. 2004 May;16(3):215-9. doi: 10.1097/00001622-200405000-00004. Curr Opin Oncol. 2004. PMID: 15069315 Review.

6

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.

Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Among authors: pignon jp. JAMA. 2004 Jul 28;292(4):470-84. doi: 10.1001/jama.292.4.470. JAMA. 2004. PMID: 15280345

7

Meta-analysis when only the median survival times are known: a comparison with individual patient data results.

Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP. Michiels S, et al. Among authors: pignon jp. Int J Technol Assess Health Care. 2005 Winter;21(1):119-25. doi: 10.1017/s0266462305050154. Int J Technol Assess Health Care. 2005. PMID: 15736523

8

Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?

Le Chevalier T, Arriagada R, Pignon JP, Scagliotti GV. Le Chevalier T, et al. Among authors: pignon jp. Lancet Oncol. 2005 Mar;6(3):182-4. doi: 10.1016/s1470-2045(05)01769-9. Lancet Oncol. 2005. PMID: 15759364

9

Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.

Dunant A, Pignon JP, Le Chevalier T. Dunant A, et al. Among authors: pignon jp. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5017s-5021s. doi: 10.1158/1078-0432.CCR-05-9006. Clin Cancer Res. 2005. PMID: 16000606 Clinical Trial.

10

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP; MAC-NPC Collaborative Group. Baujat B, et al. Among authors: pignon jp. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):47-56. doi: 10.1016/j.ijrobp.2005.06.037. Int J Radiat Oncol Biol Phys. 2006. PMID: 16377415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results